Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage
- PMID: 21830
Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage
Abstract
In a series of in vitro studies, both the soluble (plasmatic) coagulation system and the cellular (platelet-mediated) aspect of coagulation were shown to be extremely sensitive to relatively minor increases in hydrogen ion concentration. All studies became abnormal at pH 6.8. At pH 6.4, assays of the intrinsic and extrinsic coaglution systems, the polymerization of fibrinogen, and assay of the availability of platelet phospholipid (platelet factor 3) were twice prolonged over control values. Platelet aggregation was reduced by more than 50%. At pH 5.4 in vitro, platelet aggregation and plasma coagulation were both virtually abolished. Furthermore, previously formed platelet aggregates disaggregated at a slightly acid pH. Pepsin further enhanced platelet disaggregation. Because gastric acidity is normally two to four orders of magnitude greater than that which abolishes platelet aggregation and plasma clotting in vitro, and pepsin is present in abundance, we call attention to the probable antihemostatic effect of hydrocloric acid and pepsin in the upper gastrointestinal tract. This in vitro study may provide a rationale for meticulous regulation of intragastric pH in an effort to control upper gastrointestinal hemorrhage.
Similar articles
-
Anticoagulative effect of pepsin.Acta Biochim Pol. 1999;46(3):717-20. Acta Biochim Pol. 1999. PMID: 10698279
-
In vitro inhibition of platelet aggregation by bile salts.Thromb Haemost. 1980 Oct 31;44(2):62-4. Thromb Haemost. 1980. PMID: 7455992
-
Influence of cytotoxic drugs on platelet functions and coagulation in vitro. IV. Melphalan.Thromb Haemost. 1977 Feb 28;37(1):53-61. Thromb Haemost. 1977. PMID: 576517
-
[Effect of thrombolytic agents on platelets and blood coagulation system].Rinsho Byori. 1997 Oct;45(10):951-6. Rinsho Byori. 1997. PMID: 9369072 Review. Japanese.
-
Inhibition mechanisms of hematophagous invertebrate compounds acting on the host blood coagulation and platelet aggregation pathways.Biochimie. 2003 May;85(5):493-500. doi: 10.1016/s0300-9084(03)00071-3. Biochimie. 2003. PMID: 12763308 Review.
Cited by
-
Proton Pump Inhibitor Therapy before and after Endoscopic Submucosal Dissection: A Review.Diagn Ther Endosc. 2012;2012:791873. doi: 10.1155/2012/791873. Epub 2012 Jul 18. Diagn Ther Endosc. 2012. PMID: 22851882 Free PMC article.
-
High-dose vs low-dose proton pump inhibitors for upper gastrointestinal bleeding: a meta-analysis.World J Gastroenterol. 2010 May 28;16(20):2558-65. doi: 10.3748/wjg.v16.i20.2558. World J Gastroenterol. 2010. PMID: 20503458 Free PMC article.
-
Comparison of Oral versus Intravenous Proton Pump Inhibitors in Preventing Re-bleeding from Peptic Ulcer after Successful Endoscopic Therapy.Middle East J Dig Dis. 2018 Oct;10(4):236-241. doi: 10.15171/mejdd.2018.116. Epub 2018 Jul 22. Middle East J Dig Dis. 2018. PMID: 31049171 Free PMC article.
-
Optimizing the intragastric pH as a supportive therapy in upper GI bleeding.Yale J Biol Med. 1996 May-Jun;69(3):225-31. Yale J Biol Med. 1996. PMID: 9165691 Free PMC article.
-
pH-control via secretin or antacid: prophylaxia of stress ulcers in high-risk surgical patients.Intensive Care Med. 1984;10(5):239-43. doi: 10.1007/BF00256260. Intensive Care Med. 1984. PMID: 6333441
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous